• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Germline mutations in driver oncogenes and inherited lung cancer risk independent of smoking history.

作者信息

Oxnard Geoffrey R, Nguyen Kim-Son H, Costa Daniel B

机构信息

Affiliations of authors: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (GRO); Department of Medicine, Division of Medical Oncology, Stanford University Medical Center, Palo Alto, CA (KSHN); Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (DBC).

出版信息

J Natl Cancer Inst. 2014 Jan;106(1):djt361. doi: 10.1093/jnci/djt361. Epub 2013 Dec 7.

DOI:10.1093/jnci/djt361
PMID:24317178
Abstract
摘要

相似文献

1
Germline mutations in driver oncogenes and inherited lung cancer risk independent of smoking history.驱动癌基因中的种系突变与独立于吸烟史的遗传性肺癌风险。
J Natl Cancer Inst. 2014 Jan;106(1):djt361. doi: 10.1093/jnci/djt361. Epub 2013 Dec 7.
2
Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.吸烟者肺腺癌中明确的致癌驱动基因突变的频率因组织学亚型和分级吸烟剂量而异。
Lung Cancer. 2013 Jan;79(1):8-13. doi: 10.1016/j.lungcan.2012.09.018. Epub 2012 Oct 23.
3
Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China.中国表皮生长因子受体（EGFR）野生型肺腺癌患者中HER-2突变的流行病学研究。
BMC Cancer. 2016 Oct 28;16(1):828. doi: 10.1186/s12885-016-2875-z.
4
Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas.家族性肺腺癌中 HER2 跨膜结构域的新型种系突变。
J Natl Cancer Inst. 2014 Jan;106(1):djt338. doi: 10.1093/jnci/djt338. Epub 2013 Dec 7.
5
Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?不吸烟人群中的肺癌。在分子诊断和靶向治疗时代，吸烟史重要吗？
J Clin Pathol. 2013 Oct;66(10):839-46. doi: 10.1136/jclinpath-2012-201296. Epub 2013 May 9.
6
[Oncogenic drivers in daily practice improve overall survival in patients with lung adenocarcinoma].日常实践中的致癌驱动因素可改善肺腺癌患者的总生存期
Rev Mal Respir. 2016 Nov;33(9):751-756. doi: 10.1016/j.rmr.2015.12.009. Epub 2016 Mar 24.
7
EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma.表皮生长因子受体激活突变、ErbB家族的DNA拷贝数丰度与肺腺癌的预后
Oncotarget. 2016 Feb 23;7(8):9017-25. doi: 10.18632/oncotarget.7029.
8
[Advances on driver oncogenes of lung adenocarcinoma].[肺腺癌驱动癌基因的研究进展]
Zhongguo Fei Ai Za Zhi. 2013 Feb;16(2):91-6. doi: 10.3779/j.issn.1009-3419.2013.02.06.
9
Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.年轻肺腺癌患者致癌基因改变的独特患病率。
Cancer. 2017 May 15;123(10):1731-1740. doi: 10.1002/cncr.30539. Epub 2017 Feb 8.
10
Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma.肺腺癌中 DNA 修复基因的种系突变。
J Thorac Oncol. 2017 Nov;12(11):1673-1678. doi: 10.1016/j.jtho.2017.08.011. Epub 2017 Aug 24.

引用本文的文献

1
Non-small-cell lung cancer.非小细胞肺癌。
Nat Rev Dis Primers. 2024 Sep 26;10(1):71. doi: 10.1038/s41572-024-00551-9.
2
exon 20 insertion mutations and mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates.20号外显子插入突变与肺癌：关于从口服激酶抑制剂到抗体药物偶联物等已获批靶向治疗的叙述性综述
Transl Lung Cancer Res. 2023 Jul 31;12(7):1590-1610. doi: 10.21037/tlcr-23-98. Epub 2023 Jul 5.
3
A Germline Mutation in ATR Is Associated With Lung Adenocarcinoma in Asian Patients.
亚洲患者中，ATR基因的种系突变与肺腺癌相关。
Front Oncol. 2022 May 31;12:855305. doi: 10.3389/fonc.2022.855305. eCollection 2022.
4
Clinical and genomic features of Chinese lung cancer patients with germline mutations.具有胚系突变的中国肺癌患者的临床和基因组特征
Nat Commun. 2022 Mar 10;13(1):1268. doi: 10.1038/s41467-022-28840-5.
5
Characteristics of BRCA1/2 pathogenic germline mutations in chinese NSCLC patients and a comparison with HBOC.中国非小细胞肺癌患者BRCA1/2致病种系突变的特征及其与遗传性乳腺癌卵巢癌综合征的比较。
Hered Cancer Clin Pract. 2021 Feb 9;19(1):16. doi: 10.1186/s13053-021-00174-1.
6
Predisposition to Lung Adenocarcinoma in a Family Harboring the Germline V843I Mutation.携带种系V843I突变的家族中患肺腺癌的易感性。
JCO Precis Oncol. 2019 Jul 26;3. doi: 10.1200/PO.19.00104. eCollection 2019.
7
Significant Benefits of Osimertinib Against Adenosquamous Carcinoma Harboring Germline T790M Mutation.奥希替尼对携带胚系 T790M 突变的腺鳞癌的显著获益。
Oncologist. 2020 Oct;25(10):826-832. doi: 10.1634/theoncologist.2019-0938. Epub 2020 Jun 11.
8
Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients.男性乳腺癌：多基因检测在意大利患者队列中的应用结果
Diagnostics (Basel). 2020 Apr 30;10(5):269. doi: 10.3390/diagnostics10050269.
9
The duality of human oncoproteins: drivers of cancer and congenital disorders.人类癌蛋白的双重性：癌症和先天性疾病的驱动因素。
Nat Rev Cancer. 2020 Jul;20(7):383-397. doi: 10.1038/s41568-020-0256-z. Epub 2020 Apr 27.
10
Spectrum of Pathogenic Germline Mutations in Chinese Lung Cancer Patients through Next-Generation Sequencing.通过下一代测序技术在中国肺癌患者中发现的致病性种系突变谱。
Pathol Oncol Res. 2020 Jan;26(1):109-114. doi: 10.1007/s12253-019-00771-5. Epub 2019 Nov 12.